APA (7th ed.) Citation

Okada, H., Takahashi, K., Yaku, H., Kobiyama, K., Iwaisako, K., Zhao, X., . . . Seno, H. (2022). In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy. Scientific reports, 12(1), 2132-14. https://doi.org/10.1038/s41598-022-05702-0

Chicago Style (17th ed.) Citation

Okada, Hirokazu, et al. "In Situ Vaccination Using Unique TLR9 Ligand K3-SPG Induces Long-lasting Systemic Immune Response and Synergizes with Systemic and Local Immunotherapy." Scientific Reports 12, no. 1 (2022): 2132-14. https://doi.org/10.1038/s41598-022-05702-0.

MLA (9th ed.) Citation

Okada, Hirokazu, et al. "In Situ Vaccination Using Unique TLR9 Ligand K3-SPG Induces Long-lasting Systemic Immune Response and Synergizes with Systemic and Local Immunotherapy." Scientific Reports, vol. 12, no. 1, 2022, pp. 2132-14, https://doi.org/10.1038/s41598-022-05702-0.